Oncotelic Therapeutics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2016 | $-15.2M | $-15.2M | — | $804.0K |
| FY2017 | $-10.9M | $-10.9M | — | $835.0K |
| FY2018 | $-241.0K | $-241.0K | — | $80.0K |
| FY2019 | $-2.3M | $-2.3M | — | $340.7K |
| FY2020 | $-2.8M | $-2.8M | — | $2.1M |
| FY2021 | $-4.4M | $-4.4M | — | $763.3K |
| FY2022 | $-1.5M | $-1.5M | — | $902.1K |
| FY2023 | $-1.3M | $-1.3M | — | — |
| FY2024 | $-740.3K | $-740.3K | — | — |
| FY2025 | $-1.4M | $-1.4M | — | $2.4M |